UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number 001-41401

Prenetics Global Limited

11401 Granite St.

Charlotte, NC 28273

USA

Unit 703-706, K11 Atelier

728 King’s Road, Quarry Bay

Hong Kong

(Addresses of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F

EXPLANATORY NOTE

Prenetics Global Limited (the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, furnishes this Form 6-K to announce that on November 18, 2025 its Chief Executive Officer and co-founder, Danny Sheng Wu Yeung, purchased 20,118 shares of the Company's Class A Ordinary Shares at a price of $12.02 per share in the open market for a total purchase price of approximately $242,000, bringing his total holdings of Class A Ordinary Shares to 76,412.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	Prenetics Global Limited

	By:	/s/ Lo Hoi Chun
	Name:	Lo Hoi Chun
	Title:	Chief Financial Officer

Date: November 19, 2025

Prenetics Global Ltd 6-K